MedPath

The Effect of Extracorporeal Shock Wave Therapy in the Treatment of Post Burn Scars

Not Applicable
Completed
Conditions
Cicatrix, Hypertrophic
Registration Number
NCT04558944
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Brief Summary

A prospective, randomized, controlled study. The patients were divided into two groups with twenty patients per group. The control group received the standard treatment for postburn scars. The treatment group received the standard treatment and treatment of postburn scars with Extracorporeal Shock Wave Therapy 512 impulses of 0.15mJ/mm 2 in each session, twice per week for 4 weeks.

The investigators assessed the appearance of scar with the Vancouver Scar Scale (VSS), pruritus and pain with Visual Analog Scale (VAS) before the start of the treatment and at 2 weeks and 5 months after the treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients with hypertrophic post burn scars of approximately 64 cm2 surface area.
Exclusion Criteria
  • Patients younger than 18 year.
  • Pregnant women.
  • Having a known skin condition (e.g. psoriasis, skin cancer etc.).
  • Immunosuppression.
  • Hemophilia .
  • Matured scars.
  • Scars located above the lungs, the bowels, the gonads or electronic implants.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Scar appearance6 months from inclusion

Scar appearance by Vancouver Scar Scale. Minimum value 0. Maximum value 13. Higher scores mean a worse outcome.

Secondary Outcome Measures
NameTimeMethod
Scar pruritus6 months from inclusion

Pruritus measured by Visual Analogue Scale. Minimum value 0. Maximum value 10. Higher scores mean a worse outcome.

Scar pain6 months from inclusion

Pain measured by Visual Analogue Scale. Minimum value 0. Maximum value 10. Higher scores mean a worse outcome.

Trial Locations

Locations (1)

Jorge Aguilera Sáez

🇪🇸

Barcelona, Spain

Jorge Aguilera Sáez
🇪🇸Barcelona, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.